Cargando…
A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
Autores principales: | Wang, Joseph, Vogt, Beth, Sethi, Sidharth Kumar, Sampson, Matthew G., Vega-Warner, Virginia, Otto, Edgar A., Raina, Rupesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733768/ https://www.ncbi.nlm.nih.gov/pubmed/29270533 http://dx.doi.org/10.1016/j.ekir.2017.05.006 |
Ejemplares similares
-
A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake
por: Fukuoka, Kazuhito, et al.
Publicado: (2017) -
The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia
por: Block, Geoffrey A, et al.
Publicado: (2019) -
A Familial Infantile Renal Failure
por: Sethi, Sidharth K., et al.
Publicado: (2016) -
Both hypophosphatemia and hyperphosphatemia are associated with increased mortality in septic patients
por: Liu, Zheng, et al.
Publicado: (2022) -
Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
por: Miyakawa, Hirosumi, et al.
Publicado: (2021)